Guidelines Outline Hypertensive Therapy

Published Online: Thursday, July 1, 2004

New guidelines released by the National Kidney Foundation state that 20 million American adults with chronic kidney disease (CKD) should be considered in the highest risk group for developing cardiovascular disease. The guidelines, "Hypertension and Antihypertensive Agents in Chronic Kidney Disease," reported in the American Journal of Kidney Disease (May 2004), suggested that physicians can stabilize their kidney patients by reducing blood pressure levels to a maximum of 130/80 mm Hg.

The guidelines provide an integrated clinical action plan; key suggestions include:

  • Blood pressure goal of 130/80 mm Hg is appropriate for all stages of CKD
  • Protein in the urine, in addition to blood pressure, should be monitored to assess the response to antihypertensive agents
  • Lifestyle modifications to lower blood pressure and reduce cardiovascular disease risk should be recommended to all CKD patients

Latest Articles
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Vertex Pharmaceuticals has received a complete response letter from the FDA for its supplemental new drug application for ivacaftor.
As the only pharmacist serving in Congress, US Representative Earl L. “Buddy” Carter is a critical leader of efforts to pass federal legislation pertinent to pharmacists.
An Arkansas family is taking legal action against a pharmacy for dispensing the wrong medication to a 4-year-old child.
Latest Issues